NASHVILLE -- Among multiple sclerosis (MS) patients experiencing breakthrough disease on standard-dose once-a-week interferon beta 1-a (IFN-1α), switching to twice-weekly dosing may offer advantages, a researcher reported here.
More than half of patients with breakthrough disease and adequate follow-up (26/52 patients) who were switched to twice-weekly treatment had no further clinical relapses, new T2 lesions, or enhanced lesions on MRI, or worsening of Expanded Disability Status Scale (EDSS) during at least 14 months (range 14 to 192 months) of follow-up, according to Robert Baumhefner, MD, of the VA Greater Los Angeles Healthcare System..
“He first started off with chemotherapy to the trachea, and after a while he was starting to feel fine,” Diane said. “He went home after three days of chemo and had his first seizure on the porch, so they put him right back into the hospital.”
“Oftentimes, it’s hard to tell, unless there’s a suicide note, whether it was a suicide or unintentional.”
The report claims that the number of deaths by homicide rose in 2016 by 27 percent. Most of these fatalities were caused by firearms, cutting, or stabbing.
Exact numbers were published in a recent Time article. Overall, 9,716 adolescents perished by fatal injuries in 2016, which is an astounding 17 percent increase from numbers recorded just three years earlier.
The study also showed a sharp increase in both homicide and suicide rates. There were 1,963 children who died by homicide and a shocking 2,553 American children took their own lives that year.
Dr. Thomas Weiser of Stanford University Medical Center, when asked his thoughts on the study, claimed that this is something Americans need to worry about. The data here is “very concerning.”